首頁 > 市場調查報告書 > 製藥

市場調查報告書

商品編碼

1547984

全球肌肉鬆弛藥物市場研究報告 - 2024 年至 2032 年產業分析、規模、佔有率、成長、趨勢與預測

Global Muscle Relaxant Drugs Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032

出版日期: 2024年07月01日 | 出版商:

Value Market Research | 英文 170 Pages | 商品交期: 最快1-2個工作天內

價格

簡介目錄圖表

全球肌肉鬆弛藥物市場需求預計將從 2023 年的 42.3 億美元達到近 66.9 億美元的市場規模，2024-2038 年研究期間複合年成長率為 5.22%。

肌肉鬆弛劑是一類特殊的藥物，用於治療因脫水或疲勞而引起的多種肌肉不適，如痙攣、疼痛和抽筋。這些藥物不作用於中樞神經系統，而是作用於用於腦部和脊髓之間訊號傳遞的神經元。它們也在外科手術過程中用於放鬆肌肉。目前市面上經 FDA 核准的肌肉鬆弛藥物中，巴氯芬、美他沙酮和奧芬那君很少。一般來說，肌肉鬆弛劑是非常強效的藥物，會讓人上癮並可能產生副作用。用於去除臉部皺紋的藥物（如肉毒桿菌）也可以歸入此類藥物，因為它們的用途類似於鬆弛劑。

市場動態

老年人口的成長和生活方式的改變是肌肉鬆弛藥物市場的主要驅動力。全球範圍內進行的外科手術數量的增加以及使用這些藥物和麻醉劑來放鬆患者的肌肉可以進一步推動該市場的成長。污染率增加和紫外線照射會導致某些皮膚病，可以使用這些藥物來治療。在 COVID-19 封鎖期間，肌肉鬆弛藥物市場將大幅成長，因為許多人可能因缺乏體力活動而遭受肌肉不適。政府施加的嚴格規則、涉及的風險以及與藥物相關的高成本可能會掩蓋肌肉鬆弛藥物市場的成長。

研究報告涵蓋波特五力模型、市場吸引力分析和價值鏈分析。這些工具有助於清晰地了解行業結構並評估全球範圍內的競爭吸引力。此外，這些工具也對全球肌肉鬆弛藥物市場的各個細分市場進行了包容性評估。肌肉鬆弛藥物產業的成長和趨勢為本研究提供了整體方法。

市場區隔

肌肉鬆弛藥物市場報告的這一部分提供了國家和區域層面細分市場的詳細資料，從而幫助策略師確定相應產品或服務的目標人群以及即將到來的機會。

依藥物類型

骨骼肌鬆弛藥
臉部肌肉鬆弛藥物
神經肌肉阻斷劑

依給藥途徑

口服
可注射

按配銷通路

醫院藥房
零售藥房
網路藥房

區域分析

本節涵蓋區域前景，重點介紹北美、歐洲、亞太地區、拉丁美洲以及中東和非洲肌肉鬆弛藥物市場當前和未來的需求。此外，該報告重點關注所有主要地區各個應用領域的需求、估計和預測。

該研究報告還涵蓋了市場主要參與者的全面概況以及對全球競爭格局的深入了解。肌肉鬆弛藥物市場的主要參與者包括 Amneal Pharmaceuticals LLC、Ipsen Biopharmaceuticals Inc.、Merz Pharmaceuticals LLC.、Par Pharmaceutical、Endo Pharmaceuticals、Vertical Pharmaceuticals、Mallinckrodt、SteriMax、Eisai Co. Ltd、Mcelceltical Pharmaceuticals、Mallinckrodt、SteriMax、Eisai Co. Ltd、Mcelceltical Pharmaceticals LLC. 。

如果您有任何客製化要求，請寫信給我們。我們的研究團隊可以根據您的需求提供客製化報告。

區域展望
介紹
北美銷售分析
- 概覽、歷史與預測資料銷售分析
- 北美按細分市場銷售分析
- 北美按國家銷售分析
- 美國銷售分析
- 加拿大銷售分析
- 墨西哥銷售分析
歐洲銷售分析
- 概覽、歷史與預測資料銷售分析
- 歐洲按細分市場銷售分析
- 歐洲按國家銷售分析
- 英國銷售分析
- 法國銷售分析
- 德國銷售分析
- 義大利銷售分析
- 俄羅斯銷售分析
- 歐洲其他地區銷售分析
亞太地區銷售分析
- 概覽、歷史與預測資料銷售分析
- 亞太地區按細分市場銷售分析
- 亞太地區按國家銷售分析
- 中國銷售分析
- 印度銷售分析
- 日本銷售分析
- 韓國銷售分析
- 澳洲銷售分析
- 東南亞銷售分析
- 亞太地區其他地區銷售分析
拉丁美洲銷售分析
- 概覽、歷史與預測資料銷售分析
- 拉丁美洲按細分市場銷售分析
- 拉丁美洲按國家銷售分析
- 巴西銷售分析
- 阿根廷銷售分析
- 秘魯銷售分析
- 智利銷售分析
- 拉丁美洲其他地區銷售分析
中東和非洲銷售分析
- 概覽、歷史與預測資料銷售分析
- 中東和非洲按細分市場銷售分析
- 中東和非洲按國家銷售分析
- 沙烏地阿拉伯銷售分析
- 阿拉伯聯合大公國銷售分析
- 以色列銷售分析
- 南非銷售分析
- 中東其他地區和非洲銷售分析

第 9 章：肌肉鬆弛藥物公司的競爭格局

肌肉鬆弛藥物市場競爭
夥伴關係/協作/協議
併購
新產品發布
其他發展

第 10 章：公司簡介

頂級公司市佔率分析
市場集中度
Amneal Pharmaceuticals LLC

公司概況
公司收入
產品
最新動態

Ipsen Biopharmaceuticals Inc.

公司概況
公司收入
產品
最新動態

Merz Pharmaceuticals LLC.

公司概況
公司收入
產品
最新動態

Par Pharmaceutical

公司概況
公司收入
產品
最新動態

Endo Pharmaceuticals

公司概況
公司收入
產品
最新動態

Vertical Pharmaceuticals

公司概況
公司收入
產品
最新動態

Mallinckrodt

公司概況
公司收入
產品
最新動態

SteriMax

公司概況
公司收入
產品
最新動態

Eisai Co. Ltd

公司概況
公司收入
產品
最新動態

Metacel Pharmaceuticals LLC.

公司概況
公司收入
產品
最新動態

Teva Pharmaceuticals USA Inc

公司概況
公司收入
產品
最新動態

註 - 在公司概況中，財務詳細資訊和最新發展視情況而定，或對私人公司而言可能不包括在內

簡介目錄圖表

Product Code: VMR11212130

The global demand for Muscle Relaxant Drugs Market is presumed to reach the market size of nearly USD 6.69 Billion by 2032 from USD 4.23 Billion in 2023 with a CAGR of 5.22% under the study period 2024-2038.

Muscle Relaxant Drugs are a special class of drugs used in the treatment of several discomforts caused to the muscle like spasms, pain, and cramps due to dehydration or fatigue. These drugs do not act on the central nervous system but work on the neurons used for signal transmission between the brain and the spinal cord. They are used during surgical procedures as well to relax the muscles. Few of the muscle relaxant drugs currently in the market approved by the FDA are baclofen, metaxalone, and orphenadrine. Generally, muscle relaxants are very powerful drugs which are addictive and can have side effects. Drugs used for removing wrinkles on the face like Botox can also be fit under this class of drugs since their use is like that of a relaxant.

MARKET DYNAMICS

The growing geriatric population and changing lifestyles are the main drivers of the muscle relaxant drugs market. The rise in the number of surgical procedures carried out globally and the use of these drugs along with anaesthetic to relax a patient's muscle can further propel the growth of this market. Increased rate of pollution and exposure to UV rays can cause certain skin conditions which can be treated using these drugs. The market for muscle relaxant drugs will show a great deal of growth during COVID-19 lockdown since many people can suffer from muscular discomforts due to lack of physical activity. Stringent rules imposed by governments, risks involved, and high costs associated with the drugs can obscure the growth of the muscle relaxant drugs market.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of Muscle Relaxant Drugs. The growth and trends of Muscle Relaxant Drugs industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the Muscle Relaxant Drugs market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Drug Type

Skeletal Muscle Relaxant Drugs
Facial Muscle Relaxant Drugs
Neuromuscular Blocking Agents

By Route of Administration

Oral
Injectable

By Distribution Channel

Hospital Pharmacy
Retail Pharmacy
Online Pharmacy

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Muscle Relaxant Drugs market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Muscle Relaxant Drugs market include Amneal Pharmaceuticals LLC, Ipsen Biopharmaceuticals Inc., Merz Pharmaceuticals LLC., Par Pharmaceutical, Endo Pharmaceuticals, Vertical Pharmaceuticals, Mallinckrodt, SteriMax, Eisai Co. Ltd, Metacel Pharmaceuticals LLC., Teva Pharmaceuticals USA Inc. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

1. PREFACE

1.1. Report Description
- 1.1.1 Objective
- 1.1.2 Target Audience
- 1.1.3 Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
- 1.3.1 Market Research Process
- 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

2.1. Highlights of Market
2.2. Global Market Snapshot

3. MUSCLE RELAXANT DRUGS - INDUSTRY ANALYSIS

3.1. Introduction - Market Dynamics
3.2. Market Drivers
3.3. Market Restraints
3.4. Opportunities
3.5. Industry Trends
3.6. Porter's Five Force Analysis
3.7. Market Attractiveness Analysis
- 3.7.1 Market Attractiveness Analysis By Drug Type
- 3.7.2 Market Attractiveness Analysis By Route of Administration
- 3.7.3 Market Attractiveness Analysis By Distribution Channel
- 3.7.4 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

4.1. Value Chain Analysis
4.2. Raw Material Analysis
- 4.2.1 List of Raw Materials
- 4.2.2 Raw Material Manufactures List
- 4.2.3 Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
- 4.4.1 Direct Marketing
- 4.4.2 Indirect Marketing
- 4.4.3 Marketing Channel Development Trend

5. GLOBAL MUSCLE RELAXANT DRUGS MARKET ANALYSIS BY DRUG TYPE

5.1. Overview By Drug Type
5.2. Historical and Forecast Data
5.3. Analysis By Drug Type
5.4. Skeletal Muscle Relaxant Drugs Historic and Forecast Sales By Regions
5.5. Facial Muscle Relaxant Drugs Historic and Forecast Sales By Regions
5.6. Neuromuscular Blocking Agents Historic and Forecast Sales By Regions

6. GLOBAL MUSCLE RELAXANT DRUGS MARKET ANALYSIS BY ROUTE OF ADMINISTRATION

6.1. Overview By Route of Administration
6.2. Historical and Forecast Data
6.3. Analysis By Route of Administration
6.4. Oral Historic and Forecast Sales By Regions
6.5. Injectable Historic and Forecast Sales By Regions

7. GLOBAL MUSCLE RELAXANT DRUGS MARKET ANALYSIS BY DISTRIBUTION CHANNEL

7.1. Overview By Distribution Channel
7.2. Historical and Forecast Data
7.3. Analysis By Distribution Channel
7.4. Hospital Pharmacy Historic and Forecast Sales By Regions
7.5. Retail Pharmacy Historic and Forecast Sales By Regions
7.6. Online Pharmacy Historic and Forecast Sales By Regions

8. GLOBAL MUSCLE RELAXANT DRUGS MARKET ANALYSIS BY GEOGRAPHY

8.1. Regional Outlook
8.2. Introduction
8.3. North America Sales Analysis
- 8.3.1 Overview, Historic and Forecast Data Sales Analysis
- 8.3.2 North America By Segment Sales Analysis
- 8.3.3 North America By Country Sales Analysis
- 8.3.4 United States Sales Analysis
- 8.3.5 Canada Sales Analysis
- 8.3.6 Mexico Sales Analysis
8.4. Europe Sales Analysis
- 8.4.1 Overview, Historic and Forecast Data Sales Analysis
- 8.4.2 Europe By Segment Sales Analysis
- 8.4.3 Europe By Country Sales Analysis
- 8.4.4 United Kingdom Sales Analysis
- 8.4.5 France Sales Analysis
- 8.4.6 Germany Sales Analysis
- 8.4.7 Italy Sales Analysis
- 8.4.8 Russia Sales Analysis
- 8.4.9 Rest Of Europe Sales Analysis
8.5. Asia Pacific Sales Analysis
- 8.5.1 Overview, Historic and Forecast Data Sales Analysis
- 8.5.2 Asia Pacific By Segment Sales Analysis
- 8.5.3 Asia Pacific By Country Sales Analysis
- 8.5.4 China Sales Analysis
- 8.5.5 India Sales Analysis
- 8.5.6 Japan Sales Analysis
- 8.5.7 South Korea Sales Analysis
- 8.5.8 Australia Sales Analysis
- 8.5.9 South East Asia Sales Analysis
- 8.5.10 Rest Of Asia Pacific Sales Analysis
8.6. Latin America Sales Analysis
- 8.6.1 Overview, Historic and Forecast Data Sales Analysis
- 8.6.2 Latin America By Segment Sales Analysis
- 8.6.3 Latin America By Country Sales Analysis
- 8.6.4 Brazil Sales Analysis
- 8.6.5 Argentina Sales Analysis
- 8.6.6 Peru Sales Analysis
- 8.6.7 Chile Sales Analysis
- 8.6.8 Rest of Latin America Sales Analysis
8.7. Middle East & Africa Sales Analysis
- 8.7.1 Overview, Historic and Forecast Data Sales Analysis
- 8.7.2 Middle East & Africa By Segment Sales Analysis
- 8.7.3 Middle East & Africa By Country Sales Analysis
- 8.7.4 Saudi Arabia Sales Analysis
- 8.7.5 UAE Sales Analysis
- 8.7.6 Israel Sales Analysis
- 8.7.7 South Africa Sales Analysis
- 8.7.8 Rest Of Middle East And Africa Sales Analysis

9. COMPETITIVE LANDSCAPE OF THE MUSCLE RELAXANT DRUGS COMPANIES

9.1. Muscle Relaxant Drugs Market Competition
9.2. Partnership/Collaboration/Agreement
9.3. Merger And Acquisitions
9.4. New Product Launch
9.5. Other Developments

10. COMPANY PROFILES OF MUSCLE RELAXANT DRUGS INDUSTRY

10.1. Top Companies Market Share Analysis
10.2. Market Concentration Rate
10.3. Amneal Pharmaceuticals LLC
- 10.3.1 Company Overview
- 10.3.2 Company Revenue
- 10.3.3 Products
- 10.3.4 Recent Developments
10.4. Ipsen Biopharmaceuticals Inc.
- 10.4.1 Company Overview
- 10.4.2 Company Revenue
- 10.4.3 Products
- 10.4.4 Recent Developments
10.5. Merz Pharmaceuticals LLC.
- 10.5.1 Company Overview
- 10.5.2 Company Revenue
- 10.5.3 Products
- 10.5.4 Recent Developments
10.6. Par Pharmaceutical
- 10.6.1 Company Overview
- 10.6.2 Company Revenue
- 10.6.3 Products
- 10.6.4 Recent Developments
10.7. Endo Pharmaceuticals
- 10.7.1 Company Overview
- 10.7.2 Company Revenue
- 10.7.3 Products
- 10.7.4 Recent Developments
10.8. Vertical Pharmaceuticals
- 10.8.1 Company Overview
- 10.8.2 Company Revenue
- 10.8.3 Products
- 10.8.4 Recent Developments
10.9. Mallinckrodt
- 10.9.1 Company Overview
- 10.9.2 Company Revenue
- 10.9.3 Products
- 10.9.4 Recent Developments
10.10. SteriMax
- 10.10.1 Company Overview
- 10.10.2 Company Revenue
- 10.10.3 Products
- 10.10.4 Recent Developments
10.11. Eisai Co. Ltd
- 10.11.1 Company Overview
- 10.11.2 Company Revenue
- 10.11.3 Products
- 10.11.4 Recent Developments
10.12. Metacel Pharmaceuticals LLC.
- 10.12.1 Company Overview
- 10.12.2 Company Revenue
- 10.12.3 Products
- 10.12.4 Recent Developments
10.13. Teva Pharmaceuticals USA Inc
- 10.13.1 Company Overview
- 10.13.2 Company Revenue
- 10.13.3 Products
- 10.13.4 Recent Developments